15
Views
41
CrossRef citations to date
0
Altmetric
Original Article

Circulating Tachykinins (Substance P, Neurokinin A, Neuropeptide K) and the Carcinoid Flush

, , , &
Pages 97-105 | Received 22 May 1986, Accepted 05 Sep 1986, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

R. A. Anderson, K. Skorupskaite & J. Sassarini. (2019) The neurokinin B pathway in the treatment of menopausal hot flushes. Climacteric 22:1, pages 51-54.
Read now
H. Ahlman, B. Wängberg, O. Nilsson, L. Grimelius, G. Granérus, I. M. Modlin, O. Stenqvist & T. Scherstén. (1992) Aspects on Diagnosis and Treatment of the Foregut Carcinoid Syndrome. Scandinavian Journal of Gastroenterology 27:6, pages 459-471.
Read now
L. K. Kvols. (1989) Therapeutic Considerations for the Malignant Carcinoid Syndrome. Acta Oncologica 28:3, pages 433-438.
Read now
A. I. Vinik, N. Thompson, F. Eckhauser & A. R. Moattari. (1989) Clinical Features of Carcinoid Syndrome and the Use of Somatostatin Analogue in Its Management. Acta Oncologica 28:3, pages 389-402.
Read now

Articles from other publishers (37)

Karolina Skorupskaite & Richard A. Anderson. (2022) Hypothalamic neurokinin signalling and its application in reproductive medicine. Pharmacology & Therapeutics 230, pages 107960.
Crossref
Richard A. Anderson & Robert P. Millar. (2021) The roles of kisspeptin and neurokinin B in GnRH pulse generation in humans, and their potential clinical application. Journal of Neuroendocrinology.
Crossref
L. Maione, S. Christin-Maître, P. Chanson & J. Young. (2017) Contrôle de l’axe gonadotrope : nouveaux aspects physiologiques et thérapeutiques. Annales d'Endocrinologie 78, pages S31-S40.
Crossref
Dorothy M Gujral & Sanjeev Bhattacharyya. (2013) Cardiac manifestations of gastrointestinal carcinoid tumor. Future Cardiology 9:4, pages 479-488.
Crossref
Chandrasekar Palaniswamy, William H. Frishman & Wilbert S. Aronow. (2012) Carcinoid Heart Disease. Cardiology in Review 20:4, pages 167-176.
Crossref
Aaron I. Vinik & Michael Raymund C. Gonzales. (2011) New and Emerging Syndromes due to Neuroendocrine Tumors. Endocrinology and Metabolism Clinics of North America 40:1, pages 19-63.
Crossref
S. Tappin, P. Brown & L. Ferasin. (2007) An intestinal neuroendocrine tumour associated with paroxysmal ventricular tachycardia and melaena in a 10-year-old boxer. Journal of Small Animal Practice 0:0, pages 070706190438002-???.
Crossref
Wei Hou & Mitchell L. Schubert. (2008) Treatment of gastric carcinoids. Current Treatment Options in Gastroenterology 10:2, pages 123-133.
Crossref
J. M. Conlon. 2004. Tachykinins. Tachykinins 25 61 .
FRANCISCO JOSÉ LÓPEZ, PATRICIA D. FINN, MARK A. LAWSON & ANDRÉS NEGRO-VILAR. 2000. Menopause. Menopause 33 60 .
Charlie Makridis, Elvar Theodorsson, Göran Åkerström, Kjell Öberg & Lars Knutson. (2002) Increased intestinal non‐substance P tachykinin concentrations in malignant midgut carcinoid disease. Journal of Gastroenterology and Hepatology 14:5, pages 500-507.
Crossref
Rodat T. Cunningham, Kathy M. Pogue, William J. Curry, Colin F. Johnston, James M. Sloan & Keith D. Buchanan. (1999) Immunostaining for vasostatin I distinguishes between ileal and lung carcinoids. The Journal of Pathology 187:3, pages 321-325.
Crossref
Allen S. Anderson, Daniel Krauss & Roberto Lang. (1997) Cardiovascular complications of malignant carcinoid disease. American Heart Journal 134:4, pages 693-702.
Crossref
Muhammed Ashraf Memon & Heidi Nelson. (1997) Gastrointestinal carcinoid tumors. Diseases of the Colon & Rectum 40:9, pages 1101-1118.
Crossref
GERHARD E. FEURLE, MARIT HEGER, ELKE NIEBERGALL‐ROTH, STEPHAN TEYSSEN, MICHAEL FRIED, CHARLOTTE EBERLE, MANFRED V. SINGER & GERD HAMSCHER. (2009) Gastroenteropancreatic effects of xenin in the dog. The Journal of Peptide Research 49:4, pages 324-330.
Crossref
Paul C. Neary, Paul H. Redmond, Timothy Houghton, Gordon R. K. Watson & David Bouchier-Hayes. (1997) Carcinoid disease. Diseases of the Colon & Rectum 40:3, pages 349-362.
Crossref
Peter Holzer & Ulrike Holzer-Petsche. (1997) Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacology & Therapeutics 73:3, pages 219-263.
Crossref
Claude Matuchansky & Jean-Marie Launay. (1995) Serotonin, catecholamines, and spontaneous midgut carcinoid flush: Plasma studies from flushing and nonflushing sites. Gastroenterology 108:3, pages 743-751.
Crossref
Stephen T. Meller & G.F. Gebhart. (1993) Silent ischemia: A hypothetical mechanism. Neuroscience & Biobehavioral Reviews 17:2, pages 229-236.
Crossref
Stacia Poole & Neil A. Fenske. (1993) Cutaneous markers of internal malignancy. II. Paraneoplastic dermatoses and environmental carcinogens. Journal of the American Academy of Dermatology 28:2, pages 147-164.
Crossref
Alessandro Antonelli, C. Gambuzza, R. Bertoni & L. Baschieri. (2014) Calcitonin, as SMS 201–995, ameliorates the VIPoma syndrome. Journal of Endocrinological Investigation 16:1, pages 57-59.
Crossref
J. Philippe. (1992) 12 APUDomas: acute complications and their medical management. Baillière's Clinical Endocrinology and Metabolism 6:1, pages 217-228.
Crossref
Naomi E. Rance. 1992. The Human Hypothalamus in Health and Disease, Proceedings of the 17th International Summer School of Brain Research, held at the Auditorium of the University of Amsterdam. The Human Hypothalamus in Health and Disease, Proceedings of the 17th International Summer School of Brain Research, held at the Auditorium of the University of Amsterdam 221 236 .
A. Saini & J. Waxman. (1991) Management of carcinoid syndrome.. Postgraduate Medical Journal 67:788, pages 506-508.
Crossref
Siobhan J. McGrath-Linden, Colin F. Johnston, Daniel T. O'Connor, Christopher Shaw & Keith D. Buchanan. (1991) Pancreastatin-like immunoreactivity in human carcinoid disease. Regulatory Peptides 33:1, pages 55-70.
Crossref
R. ARNOLD. (2008) Therapeutic strategies in the management of endocrine GEP tumours. European Journal of Clinical Investigation 20:1, pages 82-90.
Crossref
Aaron I. Vinik, Michael K. McLeod, Lorraine M. Fig, Brahm Shapiro, Ricardo V. Lloyd & Kyung Cho. (1989) Clinical Features, Diagnosis, and Localization of Carcinoid Tumors and Their Management. Gastroenterology Clinics of North America 18:4, pages 865-896.
Crossref
Larry K. Kvols. (1989) Therapy of the Malignant Carcinoid Syndrome. Endocrinology and Metabolism Clinics of North America 18:2, pages 557-568.
Crossref
H. J. Balks, J. M. Conlon, W. Creutzfeldt & F. Stöckmann. (1989) Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush. European Journal of Clinical Pharmacology 36:2, pages 133-137.
Crossref
L. K. Kvols. 1989. Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors. Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors 65 82 .
Avrum Z. Bluming & Ronald R. Berez. (1988) Successful treatment of unstable angina in malignant carcinoid syndrome using the long-acting somatostatin analogue SMS 201-995 (Sandostatin). The American Journal of Medicine 85:6, pages 872-874.
Crossref
Abhiram Sahu, Pushpa S. Kalra, Michael G. Dube & Satya P. Kalra. (1988) Neuropeptide K suppresses feeding in the rat. Regulatory Peptides 23:2, pages 135-143.
Crossref
H. J. BALKS, J. M. CONLON, W. CREUTZFELDT & F. STÖCKMANN. (2008) CIRCULATING BRADYKININ‐LIKE IMMUNOREACTIVITY AND THE PENTAGASTRIN‐INDUCED CARCINOID FLUSH. Clinical Endocrinology 29:2, pages 141-151.
Crossref
J. Michael Conlon, Carolyn F. Deacon, Lars Grimelius, Bjorn Cedermark, Richard F. Murphy, Lars Thim & Werner Creutzfeldt. (1988) Neuropeptide K-(1–24)-peptide: Storage and release by carcinoid tumors. Peptides 9:4, pages 859-866.
Crossref
H. J. BALKS, L. THIM & J. M. CONLON. (2008) CIRCULATION OF A FRAGMENT OF HAEMOGLOBIN α‐CHAIN DURING A PENTAGASTRIN‐INDUCED FLUSH IN PATIENTS WITH METASTATIC CARCINOID TUMOURS. Clinical Endocrinology 28:3, pages 261-269.
Crossref
D G Grahame-Smith. (1987) What is the cause of the carcinoid flush?. Gut 28:11, pages 1413-1416.
Crossref
Werner Creutzfeldt & Fritz Stöckmann. (1987) Carcinoids and carcinoid syndrome. The American Journal of Medicine 82:5, pages 4-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.